NCT04438681Active, not recruiting
Evaluation of a Plasma Protein Profile as a Predictive Biomarker for Metastatic Relapse in Triple Negative Breast Cancer Patients
INSTIGO Trial: Evaluation of a Plasma Protein Profile as a Predictive Biomarker for Metastatic Relapse in Triple Negative Breast Cancer Patients
Source: ClinicalTrials.gov · Last updated 4 Dec 2025
Brief summary (registry, in English)
The INSTIGO study aims to assess a plasma protein profile at different stages of patient follow-up as a predictive factor of metastatic recurrence in triple negative breast cancer. It also aims to look at other potential biomarkers of metastatic relapse such as Tumor-infiltrating Lymphocytes, circulating tumor DNA, figurative elements in blood, or a tumor RNA signature.
- Status (registry)
- Active, not recruiting
- Study type
- Observational
- Enrollment
- 90 (estimated)
- First submitted
- 15 Jun 2020
- Start date
- 27 Nov 2020
- Primary completion date
- 9 Nov 2026
- Lead sponsor
- Centre Jean Perrin
- Diseases
- Triple-negative breast cancer
- NCT number
- NCT04438681
What you commit to
- Study type: Observational
- Planned participants: 90
- From 27 Nov 2020 to the primary completion date, 9 Nov 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- Persons deprived of their freedom or under guardianship or incapable of giving consent
- Refusal to participate
Who the study is looking for
- Female
- Age \> 18 years
- Diagnosed with primitive, non-metastatic, histologically proved, triple negative breast cancer
- Patient able to understand the French language
- Patient affiliated to social security
- Obtaining signed written consent
Age in the registry: 18 years to - · Sex: Female · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Centre Jean Perrin Coordinator of this site? Confirm its status | Clermont-Ferrand | France | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.